ACADIA Pharma (ACAD) P/E Ratio
P/E Ratio as of Jun 30, 2025: 15.70
Average16.11
Median16.14
Minimum15.54
Maximum16.71
15.70
Past Month0.00 (0.00%)
The P/E ratio for ACADIA Pharma (ACAD) is 15.70 as of Jun 30, 2025. This represents a decrease of -57.97% compared to its 12-month average P/E ratio of 37.35. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
ACADIA Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ACADIA Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ACADIA Pharma to industry peers.
ACADIA Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
ACADIA Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing ACADIA Pharma to industry peers.
ACADIA Pharma (ACAD) P/E Ratio Insights
See ACADIA Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ACADIA Pharma (ACAD)
Order type
Buy in
Order amount
Est. shares
0 shares
ACADIA Pharma (ACAD) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $21.465 | 15.63 |
| May 1, 2025 | $14.57 | 10.71 |
| Apr 1, 2025 | $16.32 | 12.00 |
| Mar 3, 2025 | $18.16 | 13.35 |
| Feb 3, 2025 | $18.51 | 23.96 |
| Jan 2, 2025 | $18.66 | 24.16 |
ACADIA Pharma (ACAD) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 15.70 | -33.89% |
| 2024 | 23.75 | -169.24% |
| 2023 | -34.30 | +190.19% |
| 2022 | -11.82 | -47.00% |
| 2021 | -22.30 | -25.32% |
| 2020 | -29.86 | — |
FAQs About ACADIA Pharma (ACAD) P/E ratio
The latest P/E ratio of ACADIA Pharma (ACAD) is 15.70, as of Jun 30, 2025. This is calculated based on its current stock price and earnings per share (EPS).
ACADIA Pharma’s last 12-month average P/E ratio is 37.35, compared to its current P/E ratio of 15.70. This reflects a decrease of -57.97%.
ACADIA Pharma’s current P/E ratio of 15.70 is lower than its last 12-month average P/E of 37.35. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
ACADIA Pharma’s average P/E ratio over the last 3 years is -93.44. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
ACADIA Pharma’s average P/E ratio over the last 5 years is -64.43. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.